Evidence map›Paper›PMID 26385351›Full record

ArticleBlood2015

Hematopoietic stem cells develop in the absence of endothelial cadherin 5 expression.

Heidi Anderson, Taylor C Patch, Pavankumar N G Reddy, Elliott J Hagedorn, Peter G Kim, Kathleen A Soltis, Michael J Chen, Owen J Tamplin, Maike Frye, Glenn A MacLean and 13 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Programming to S1PR1Circulation research · 2021
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Analysis of Hematopoietic Stem Progenitor Cell Metabolism.Journal of visualized experiments : JoVE · 2019
    Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Specification and function of hemogenic endothelium during embryogenesis.Cellular and molecular life sciences : CMLS · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 2 countries.

Heidi AndersonDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA;
Taylor C PatchDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA;
Pavankumar N G ReddyHarvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA;
Elliott J HagedornHarvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA;
Peter G KimDivision of Hematology/Oncology, Boston Children's Hospital, Boston, MA;
Kathleen A SoltisDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA;
Michael J ChenHarvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA;
Owen J TamplinHarvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA;
Maike FryeMax Planck Institute for Molecular Biomedicine, Münster, Germany;
Glenn A MacLeanHarvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA;
Kathleen HübnerDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA;
Daniel E BauerHarvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA; Harvard Stem Cell Institute, Cambridge, MA;
John P KankiDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA; and.
Guillaume VoginDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA;
Nicholas C HustonDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA;
Minh NguyenDivision of Hematology/Oncology, Boston Children's Hospital, Boston, MA;
Yuko FujiwaraHarvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA;
Barry H PawDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA;
Dietmar VestweberMax Planck Institute for Molecular Biomedicine, Münster, Germany;
Leonard I ZonHarvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA; Harvard Stem Cell Institute, Cambridge, MA; Howard Hughes Medical Institute, Boston, MA.
Stuart H OrkinHarvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA; Harvard Stem Cell Institute, Cambridge, MA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA; and Howard Hughes Medical Institute, Boston, MA.
George Q DaleyHarvard Medical School, Boston, MA; Division of Hematology/Oncology, Boston Children's Hospital, Boston, MA; Harvard Stem Cell Institute, Cambridge, MA; Howard Hughes Medical Institute, Boston, MA.
Dhvanit I ShahDivision of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, MA; Harvard Medical School, Boston, MA; Harvard Stem Cell Institute, Cambridge, MA;ORCID http://orcid.org/0000-0002-3173-2402
Boston Children's Hospital · USBrigham and Women's Hospital · USMax Planck Institute for Molecular Biomedicine · DEDana-Farber Cancer Institute · US

Funding

TRANSCRIPTION FACTOR GATA-1 IN TERMINAL ERYTHROID DEVELOPMENTP01HL032262 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI BAUER, DANIEL EVAN · 1985 to 2021
$38.9M
CORE--ZEBRAFISHP30DK049216 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1999 to 2015
$14.3M
Customized stem cells for clinical application in blood disordersR24DK092760 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI COLLINS, JAMES J, DALEY, GEORGE Q · 2011 to 2018
$10.7M
Human Pluripotent Stem Cell and Progenitor Models of Cardiac and Blood DiseasesU01HL100001 · NHLBI · BOSTON CHILDREN'S HOSPITAL · PI DALEY, GEORGE Q, ORKIN, STUART H · 2009 to 2015
$8.9M
MOLECULAR ANALYSIS OF NORMAL AND TYHALASSEMIC DNAR01HL032259 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ORKIN, STUART H · 1985 to 2022
$8.8M
Cancer Biology in the ZebrafishR01CA103846 · NCI · CHILDREN'S HOSPITAL BOSTON · PI ZON, LEONARD IRA · 2003 to 2022
$7.5M
EMBRYONIC HEMATOPOIESISR01HL048801 · NHLBI · CHILDREN'S HOSPITAL BOSTON · PI ZON, LEONARD IRA · 1992 to 2016
$5.7M
Biomechanical Stimulation of Hemogenic Endothelial Cells to Develop Clinical-Grade Hematopoietic Stem CellsR01HL131645 · NHLBI · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI SHAH, DHVANIT INDRAVADAN · 2016 to 2019
$1.6M
Zebrafish Genetics to Identify Genes Involved in HematopoiesisK01DK085217 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI SHAH, DHVANIT INDRAVADAN · 2010 to 2014
$794k
Epigenetic regulation of BCL11A in the hemoglobin switchK08DK093705 · NIDDK · BOSTON CHILDREN'S HOSPITAL · PI BAUER, DANIEL EVAN · 2012 to 2016
$679k
Analysis of Mammalian Hematological Diseases in a Mouse Atpif1 Deficient ModelsR03DK100672 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI SHAH, DHVANIT INDRAVADAN · 2014 to 2015
$177k
NCI NIH HHS R01 CA103846NHLBI NIH HHS P01 HL032262NHLBI NIH HHS R01 HL032259NHLBI NIH HHS R01 HL048801NHLBI NIH HHS R01 HL131645NHLBI NIH HHS U01 HL100001NIDDK NIH HHS K01 DK085217NIDDK NIH HHS K08 DK093705NIDDK NIH HHS P30 DK049216NIDDK NIH HHS R03 DK100672NIDDK NIH HHS R24 DK092760
6 · The paper itself

Abstract

Rare endothelial cells in the aorta-gonad-mesonephros (AGM) transition into hematopoietic stem cells (HSCs) during embryonic development. Lineage tracing experiments indicate that HSCs emerge from cadherin 5 (Cdh5; vascular endothelial-cadherin)(+) endothelial precursors, and isolated populations of Cdh5(+) cells from mouse embryos and embryonic stem cells can be differentiated into hematopoietic cells. Cdh5 has also been widely implicated as a marker of AGM-derived hemogenic endothelial cells. Because Cdh5(-/-) mice embryos die before the first HSCs emerge, it is unknown whether Cdh5 has a direct role in HSC emergence. Our previous genetic screen yielded malbec (mlb(bw306)), a zebrafish mutant for cdh5, with normal embryonic and definitive blood. Using time-lapse confocal imaging, parabiotic surgical pairing of zebrafish embryos, and blastula transplantation assays, we show that HSCs emerge, migrate, engraft, and differentiate in the absence of cdh5 expression. By tracing Cdh5(-/-)green fluorescent protein (GFP)(+/+) cells in chimeric mice, we demonstrated that Cdh5(-/-)GFP(+/+) HSCs emerging from embryonic day 10.5 and 11.5 (E10.5 and E11.5) AGM or derived from E13.5 fetal liver not only differentiate into hematopoietic colonies but also engraft and reconstitute multilineage adult blood. We also developed a conditional mouse Cdh5 knockout (Cdh5(flox/flox):Scl-Cre-ER(T)) and demonstrated that multipotent hematopoietic colonies form despite the absence of Cdh5. These data establish that Cdh5, a marker of hemogenic endothelium in the AGM, is dispensable for the transition of hemogenic endothelium to HSCs.

Indexed as

AnimalsAntigens, CDCadherin 5CadherinsCell DifferentiationCell LineageElectroporationEmbryo, MammalianEmbryo, NonmammalianFlow CytometryHemangioblastsHematopoiesisHematopoietic Stem CellsImmunohistochemistryMesonephrosMiceAntigens, CDCadherin 5Cadherins

Identifiers

PMID26385351
PMCPMC4692141
OpenAlexW2408594618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.